vs

Side-by-side financial comparison of CHIMERA INVESTMENT CORP (CIM) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

CHIMERA INVESTMENT CORP is the larger business by last-quarter revenue ($66.2M vs $41.8M, roughly 1.6× Neuronetics, Inc.). CHIMERA INVESTMENT CORP runs the higher net margin — 42.8% vs -17.2%, a 60.1% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 0.5%). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 0.8%).

Chimera Investment Corp is a US-based real estate investment trust (REIT) primarily investing in residential mortgage-backed securities, residential and commercial mortgage loans, and other real estate-related financial assets. It delivers sustainable risk-adjusted returns for shareholders via regular dividend distributions from its investment portfolio.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

CIM vs STIM — Head-to-Head

Bigger by revenue
CIM
CIM
1.6× larger
CIM
$66.2M
$41.8M
STIM
Growing faster (revenue YoY)
STIM
STIM
+85.2% gap
STIM
85.7%
0.5%
CIM
Higher net margin
CIM
CIM
60.1% more per $
CIM
42.8%
-17.2%
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
0.8%
CIM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CIM
CIM
STIM
STIM
Revenue
$66.2M
$41.8M
Net Profit
$28.3M
$-7.2M
Gross Margin
52.0%
Operating Margin
42.6%
-12.1%
Net Margin
42.8%
-17.2%
Revenue YoY
0.5%
85.7%
Net Profit YoY
119.3%
43.2%
EPS (diluted)
$0.05
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIM
CIM
STIM
STIM
Q4 25
$66.2M
$41.8M
Q3 25
$65.0M
$37.3M
Q2 25
$66.0M
$38.1M
Q1 25
$69.2M
$32.0M
Q4 24
$65.8M
$22.5M
Q3 24
$66.5M
$18.5M
Q2 24
$67.3M
$16.4M
Q1 24
$65.1M
$17.4M
Net Profit
CIM
CIM
STIM
STIM
Q4 25
$28.3M
$-7.2M
Q3 25
$-580.0K
$-9.0M
Q2 25
$35.5M
$-10.1M
Q1 25
$167.3M
$-12.7M
Q4 24
$-146.5M
$-12.7M
Q3 24
$136.5M
$-13.3M
Q2 24
$56.7M
$-9.8M
Q1 24
$129.5M
$-7.9M
Gross Margin
CIM
CIM
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
CIM
CIM
STIM
STIM
Q4 25
42.6%
-12.1%
Q3 25
-0.5%
-19.6%
Q2 25
54.3%
-21.1%
Q1 25
-34.4%
Q4 24
-222.6%
-51.0%
Q3 24
-41.7%
Q2 24
84.2%
-51.7%
Q1 24
-39.4%
Net Margin
CIM
CIM
STIM
STIM
Q4 25
42.8%
-17.2%
Q3 25
-0.9%
-24.3%
Q2 25
53.7%
-26.6%
Q1 25
241.7%
-39.6%
Q4 24
-222.6%
-56.4%
Q3 24
205.4%
-72.0%
Q2 24
84.2%
-59.8%
Q1 24
198.8%
-45.2%
EPS (diluted)
CIM
CIM
STIM
STIM
Q4 25
$0.05
$-0.10
Q3 25
$-0.27
$-0.13
Q2 25
$0.17
$-0.15
Q1 25
$1.77
$-0.21
Q4 24
$-2.06
$-0.34
Q3 24
$1.39
$-0.44
Q2 24
$0.41
$-0.33
Q1 24
$1.36
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIM
CIM
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$278.6M
$28.1M
Total DebtLower is stronger
$251.5M
$65.8M
Stockholders' EquityBook value
$2.6B
$22.4M
Total Assets
$15.8B
$141.6M
Debt / EquityLower = less leverage
0.10×
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIM
CIM
STIM
STIM
Q4 25
$278.6M
$28.1M
Q3 25
$491.5M
$28.0M
Q2 25
$250.2M
$11.0M
Q1 25
$253.3M
$20.2M
Q4 24
$84.0M
$18.5M
Q3 24
$97.3M
$20.9M
Q2 24
$162.3M
$42.6M
Q1 24
$169.0M
$47.7M
Total Debt
CIM
CIM
STIM
STIM
Q4 25
$251.5M
$65.8M
Q3 25
$251.0M
$65.7M
Q2 25
$135.2M
$55.5M
Q1 25
$134.9M
$55.3M
Q4 24
$134.6M
$55.2M
Q3 24
$134.4M
$46.0M
Q2 24
$62.4M
$59.8M
Q1 24
$59.4M
Stockholders' Equity
CIM
CIM
STIM
STIM
Q4 25
$2.6B
$22.4M
Q3 25
$2.6B
$27.4M
Q2 25
$2.6B
$27.1M
Q1 25
$2.6B
$35.5M
Q4 24
$2.5B
$27.7M
Q3 24
$2.7B
$9.4M
Q2 24
$2.6B
$19.4M
Q1 24
$2.6B
$27.7M
Total Assets
CIM
CIM
STIM
STIM
Q4 25
$15.8B
$141.6M
Q3 25
$15.1B
$145.5M
Q2 25
$14.9B
$134.7M
Q1 25
$13.2B
$142.0M
Q4 24
$13.1B
$140.9M
Q3 24
$13.7B
Q2 24
$13.1B
$96.8M
Q1 24
$12.5B
$103.8M
Debt / Equity
CIM
CIM
STIM
STIM
Q4 25
0.10×
2.94×
Q3 25
0.10×
2.40×
Q2 25
0.05×
2.05×
Q1 25
0.05×
1.56×
Q4 24
0.05×
1.99×
Q3 24
0.05×
4.90×
Q2 24
0.02×
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIM
CIM
STIM
STIM
Operating Cash FlowLast quarter
$-248.9M
$908.0K
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
-8.78×
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIM
CIM
STIM
STIM
Q4 25
$-248.9M
$908.0K
Q3 25
$-137.5M
$-785.0K
Q2 25
$-7.4M
$-3.5M
Q1 25
$48.8M
$-17.0M
Q4 24
$205.7M
$-8.6M
Q3 24
$41.4M
$-5.4M
Q2 24
$69.0M
$-5.0M
Q1 24
$57.3M
$-12.0M
Free Cash Flow
CIM
CIM
STIM
STIM
Q4 25
$692.0K
Q3 25
$-899.0K
Q2 25
$-3.8M
Q1 25
$-17.2M
Q4 24
$-8.7M
Q3 24
$-5.8M
Q2 24
$-5.6M
Q1 24
$-12.4M
FCF Margin
CIM
CIM
STIM
STIM
Q4 25
1.7%
Q3 25
-2.4%
Q2 25
-9.9%
Q1 25
-53.8%
Q4 24
-38.6%
Q3 24
-31.3%
Q2 24
-34.0%
Q1 24
-71.1%
Capex Intensity
CIM
CIM
STIM
STIM
Q4 25
0.5%
Q3 25
0.3%
Q2 25
0.7%
Q1 25
0.7%
Q4 24
0.4%
Q3 24
2.1%
Q2 24
3.7%
Q1 24
2.2%
Cash Conversion
CIM
CIM
STIM
STIM
Q4 25
-8.78×
Q3 25
Q2 25
-0.21×
Q1 25
0.29×
Q4 24
Q3 24
0.30×
Q2 24
1.22×
Q1 24
0.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons